Cancer Therapies, Selling on History and the BIG NASD(y) picture.
No ratings
Cancer Therapies, selling on history and the big NASD(y) picture. When SmallCap Digest first looked at biotech Cel-SCI (CVM: AMEX) at the beginning of 2003, it was trading at 18-20 cents. We felt that once the shares breached 28-30 cents, a new up-trend w